HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.

HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.

Item
http://www.wikidata.org/entity/Q54059113
Emergence of minor drug-resistant HIV-1 variants after triple antiretroviral prophylaxis for prevention of vertical HIV-1 transmissionAntiretroviral therapy initiation before, during, or after pregnancy in HIV-1-infected women: maternal virologic, immunologic, and clinical response.Response to antiretroviral therapy (ART): comparing women with previous use of zidovudine monotherapy (ZDVm) in pregnancy with ART naïve womenGerman-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008Gender-specific considerations in the antiretroviral management of HIV-infected women.Updates to the World Health Organization's Recommendations for the Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in InfantsAIDS in pregnancy, part II: Treatment in the era of highly active antiretroviral therapy and management of obstetric, anesthetic, and pediatric issues.Review of HIV antiretroviral drug resistance.Adherence to antiretrovirals among US women during and after pregnancy.HIV-1 Drug Resistance by Ultra-Deep Sequencing Following Short Course Zidovudine, Single-Dose Nevirapine, and Single-Dose Tenofovir with Emtricitabine for Prevention of Mother-to-Child Transmission.British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review).Gene-expression profiling of HIV-1 infection and perinatal transmission in Botswana.High rates of baseline antiretroviral resistance among HIV-infected pregnant women in an HIV referral centre in Rio de Janeiro, Brazil.Prevalence of the T215Y mutation in human immunodeficiency virus type 1-infected pregnant women in a New York cohort, 1995--1999.Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission.Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV.British HIV Association guidelines for the management of HIV infection in pregnant women 2012
P2860

HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.

Item
http://www.wikidata.org/entity/Q54059113
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
HIV-1 genotypic zidovudine dru ...... ants Transmission Study Group.
@en
HIV-1 genotypic zidovudine dru ...... ants Transmission Study Group.
@nl
type
label
HIV-1 genotypic zidovudine dru ...... ants Transmission Study Group.
@en
HIV-1 genotypic zidovudine dru ...... ants Transmission Study Group.
@nl
prefLabel
HIV-1 genotypic zidovudine dru ...... ants Transmission Study Group.
@en
HIV-1 genotypic zidovudine dru ...... ants Transmission Study Group.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
HIV-1 genotypic zidovudine dru ...... ants Transmission Study Group.
@en
P2093
P304
P31
P356
10.1097/00002030-200002180-00008
P407
P433
P478
P577
P698